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        Introduction 
  The centrosome is the major microtubule organization center 
of animal cells, where it nucleates interphase microtubules re-
sponsible for cell polarity and organizes mitotic spindles for 
the bipolar separation of sister chromatids (  Meraldi and Nigg, 
2002  ). Numerical and structural centrosome aberrations have 
been implicated in almost all types of cancer cells (  Saunders, 
2005  ). Despite the apparent link between centrosome amplifi  -
cation and cancer, research is still in the early stages of under-
standing the molecular mechanisms of centrosome regulation 
and its deregulation in human diseases. Centro some aberrations 
have been implicated in the generation of multipolar mitotic 
spindles and chromosomal instability during tumor develop-
ment and progression (  Saunders, 2005  ). The proline-directed 
phosphatase Cdc14 has been extensively studied in budding 
yeast where, from G1 until early anaphase, Cdc14 is seques-
tered in an inactive state in the nucleolus (  Shou et al., 1999  ; 
  Visintin et al., 1999  ). Cdc14 is activated after release from the 
nucleolus and functions primarily to inactivate Cdk activity 
at the end of mitosis, thereby allowing reentry into G1 phase 
(  Stegmeier and Amon, 2004  ). Cells that lack Cdc14 are un-
able to exit from mitosis, with defects in both the movement of 
chromosomes to the spindle poles and the elongation of anaphase 
spindles (  Higuchi and Uhlmann, 2005  ). Human cells possess 
two Cdc14 paralogue, Cdc14A and Cdc14B, identifi  ed based 
on their sequence similarity to the budding yeast Cdc14 (  Li 
et al., 1997  ). Studies suggest that Cdc14A and Cdc14B may 
be deregulated in various cancer cells including mantle cell 
lymphoma, breast cancer, prostate cancer, and acute myeloid 
leukemia (  Wong et al., 1999  ;   Martinez et al., 2003  ;   Ashida 
et al., 2004  ;   Yu et al., 2004  ;   Neben et al., 2005  ;   Rubio-Moscardo 
et al., 2005  ). Recent fi  ndings indicate that Cdc14A and Cdc14B 
may be involved in distinctive cellular functions. Although 
Cdc14A regulates centrosome separation and cytokinesis (  Kaiser 
et al., 2002  ;   Mailand et al., 2002  ), Cdc14B may participate 
in the maintenance of nuclear structure (  Nalepa and Harper, 
2004  ), regulation of mitotic exit through SIRT2 (  Dryden et al., 
2003  ), microtubule stability (  Cho et al., 2005  ), and G1 length 
through Skp2 (  Rodier et al., 2008  ). Interestingly, previous stud-
ies, including ours, have shown that a fraction of endogenous 
and GFP-tagged Cdc14B associated with centrosomes (  Nalepa 
and Harper, 2004  ;   Cho et al., 2005  ). Yet, the functional sig-
nifi  cance of Cdc14B in centrosome cycle regulation has never 
been explored. Here, we investigate the functional relationship 
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GFP localized in nuclei/nucleoli (  Cho et al., 2005  ) and was 
absent from the centrosomes in virtually all the interphase cells 
examined. In contrast, wild-type Cdc14B-GFP (Cdc14B 
WT -GFP) 
was found to associate with centrosomes in     75% of GFP-
positive interphase cells (  Fig. 2 B  ). Although these fi  ndings sug-
gest that catalytic activity is essential for Cdc14B centrosomal 
localization, its perturbation may also inhibit Cdc14B nucleo-
cytoplasmic shuttling ability, which indirectly prevents Cdc14B 
from reaching centrosomes in interphase cells where the nuclear 
envelope is still intact. To exclude this possibility, we studied 
the localization of Cdc14B 
C314S  -GFP at the centrosomes of 
mitotic cells where the nuclear envelopes have disassembled. 
As shown in   Fig. 2  , no Cdc14B 
C314S  -GFP was found to associate 
between Cdc14B and centriole number control in human cells 
using both RNA interference and a drug-induced centriole over-
duplication system. 
  Results 
  Cdc14B centrosomal retention requires 
Cdc14B phosphatase activity 
  Cdc14B has been shown to associate with distinctive cellular 
structures such as the nucleolus, nuclear fi  lament, centrosome, 
and the spindle midzone and midbody (  Kaiser et al., 2002  ; 
  Mailand et al., 2002  ;   Nalepa and Harper, 2004  ;   Cho et al., 
2005  ), and to undergo active nucleocytoplasmic translocation 
(  Bembenek et al., 2005  ). To explore the functional signifi  cance 
of centrosomal Cdc14B, we fi  rst examined whether centro-
somal localization of Cdc14B was cell cycle  –  dependent using 
a chicken anti-Cdc14B antibody. After preextraction and fi  xa-
tion of U2OS cells, immunofl  uorescence analysis revealed that 
Cdc14B partially colocalized with centrin, a marker that stains 
at the distal lumen of centrioles, in addition to the nucleolar, 
intracellular bridge (  Fig. 1 A  ) and midzone (not depicted) local-
ization previously characterized using other anti-Cdc14B anti-
bodies (  Kaiser et al., 2002  ;   Mailand et al., 2002  ;   Nalepa and 
Harper, 2004  ;   Cho et al., 2005  ). Depending on the centriole 
confi  guration during different stages of the cell cycle (  Tsou and 
Stearns, 2006a  ;   Nigg, 2007  ), Cdc14B associates with each of 
the disengaged centrioles in G1 and late M phase but only one 
of the engaged centrioles in S, G2, and early M phase (  Fig. 1 A  ). 
Cdc14B-GFP also showed a similar cell cycle  –  dependent cen-
triole localization pattern (Fig. S1, available at http://www.jcb
.org/cgi/content/full/jcb.200710127/DC1). We believe that the 
reason we and others previously did not observe centriole-
associated Cdc14B with the rabbit anti-Cdc14B antibodies (  Kaiser 
et al., 2002  ;   Cho et al., 2005  ) was that these antibodies might 
react with epitopes that were not exposed at centrioles under 
the extraction/fi  xation conditions. In fact, Nalepa and Harper 
(  2004  ) found that the centrosomal Cdc14B only became visible 
after Triton X-100 extraction before fi  xation using another 
rabbit anti-Cdc14B antibody. To independently evaluate the centro-
somal association of Cdc14B, we purifi  ed centrosome fractions 
from asynchronized HeLa cells by discontinuous sucrose gradi-
ent centrifugation according to a published protocol (  Moudjou 
and Bornens, 1998  ). Proteins in each fraction were resolved by 
SDS-PAGE and analyzed by Western blotting. At the expected 
    60% sucrose density, fractions 14  –  17 contained the most abun-
dant amounts of     -tubulin, an archetypical centrosomal marker. 
In parallel, Cdc14B was highly enriched in those    -tubulin – 
containing centrosomal fractions (  Fig. 1 B  , top). Moreover, when 
a purifi  ed centrosomal fraction (fraction 15) was subject to 
immunostaining, we found that Cdc14B but not nucleolin, a non-
centrosomal protein, stained positive at the purifi  ed centrosomes 
(  Fig. 1 B  , bottom). Together, these data suggest that a fraction of 
Cdc14B phosphatase specifi  cally associates with centrioles. 
  To investigate whether Cdc14B catalytic activity is required 
for Cdc14B centrosome localization, we assessed the centro-
somal localization of a catalytic   “  dead  ”   Cdc14B 
C314S   mutant 
(  Cho et al., 2005  ). As shown in   Fig. 2 (A and B  ), Cdc14B 
C314S -
  Figure 1.       A fraction of Cdc14B associates with centrioles  . (A) Overlay im-
ages depict partial colocalization of endogenous Cdc14B (red) with cen-
trin (green) in U2OS cells during different stages of the cell cycle. Stages 
of the cell cycle were determined by centrin-labeled centrioles and DAPI-
stained DNA (blue). Arrows indicate centrin and Cdc14B-labeled centri-
oles. Magniﬁ  ed images of centrioles are shown in the insets. Bar, 5   μ  m. 
(B, top) Cdc14B cofractionates with     -tubulin. Lysates of asynchronized 
HeLa cells were fractionated on a 50  –  70% sucrose gradient. Fractions 
4  –  22 were analyzed by Western blotting with     -tubulin and Cdc14B anti-
bodies. (bottom) Cdc14B but not nucleolin (a noncentrosomal protein) 
costains with     -tubulin on puriﬁ  ed centrosomes (top, fraction 15).     477 CDC14B, A NEGATIVE REGULATOR OF CENTRIOLE DUPLICATION   •   Wu et al.
its nucleocytoplasmic shuttling activity and thus supports the 
possibility that Cdc14B centrosomal localization requires its 
catalytic activity. We previously demonstrated that the cytoplas-
mic translocation/microtubule bundling ability of Cdc14B 
C314S  
was impaired but restored when an additional mutation (KKIR29-
32AAIA, Cdc14B 
KKIR  ) of a potential NLS was introduced to 
the Cdc14B 
C314S   mutant (KKIR29-32AAIA+C314S, Cdc14B 
K & C ; 
  Cho et al., 2005  ). Interestingly, introduction of this mutation 
also restored Cdc14B 
C314S   localization to centrosomes (  Fig. 2  ). 
Because breakdown of the nuclear/cytoplasmic barrier in mitosis 
did not restore Cdc14B 
C314S   to centrosomes (  Fig. 2  ), this fi  nding 
indicates that the additional KKIR mutation not only helps 
Cdc14B 
C314S   regain cytoplasmic translocation but also acts as 
a gain-of-function mutant that facilitates Cdc14B 
C314S   to  re-
associate with centrosomes. 
  Ablation of Cdc14B leads to centriole 
ampliﬁ  cation 
  To determine whether Cdc14B plays a role in centrosome cycle 
regulation, we took a Cdc14B knockdown approach. We fi  rst 
attempted to establish stable cell lines in which endogenous 
Cdc14B could be conditionally knocked down. In search of 
siRNA oligos to deplete the endogenous Cdc14B, we found that 
an oligo corresponding to nucleotide position 1,234  –  1,254 rela-
tive to the Cdc14B start codon was most effective in ablating 
Cdc14B expression. We cloned this siRNA oligo into a pSuperior-
neo-GFP vector and the resulting plasmid was transfected 
into TREx HeLa cells to obtain Cdc14B knockdown stable 
clones. Western blot analysis showed a reduction of endogenous 
Cdc14B expression in two of the representative clones (clones 
No. 2 and 3) in the presence of tetracycline (  Fig. 3 A  ). Consis-
tently, real-time quantitative RT-PCR showed that the level of 
Cdc14B mRNA level was also decreased in these two clones 
(unpublished data). The same siRNA could also knock down 
Cdc14B-GFP expression in U2OS Tet-On cells, confi  rming the 
target specifi  city of the Cdc14B siRNA (  Fig. 3 A  ). Moreover, 
immunostaining with the anti-Cdc14B antibody revealed that 
centrosomal Cdc14B expression was reduced in Cdc14BsiRNA 
cells (Fig. S2 A, available at http://www.jcb.org/cgi/content/
full/jcb.200710127/DC1), though the effi  ciency of knockdown 
varied in each cell. Careful examination of those Cdc14B knock-
down clones revealed a centriole amplifi  cation phenotype (  Fig. 3, 
B and C  ). In comparison with the parental TREx HeLa and 
clone No. 1, which did not exhibit any reduction of Cdc14B ex-
pression (  Fig. 3 A  ), clones No. 2 and 3 showed two- to threefold 
increases in the number of cells with more than four centrioles 
(  Fig. 3, B and C  ) judged by immunostaining with an anti-
centrin antibody. The centriole number usually ranged from 5 to 
20 with the majority around six to eight centrioles per cell. Sim-
ilar results were obtained (Fig. S2 B) when    -tubulin  was  used 
as a centrosome marker (Fig. S2 C). To ascertain the specifi  city 
of Cdc14B knockdown phenotype, we tested a Cdc14B siRNA 
oligo pool (SMARTpool containing four different Cdc14B 
siRNA oligos) and a small hairpin RNA (shRNA) designated as 
pSuperCdc14BshRNA-E9, each targeting different regions of 
Cdc14B mRNA sequences in transient and stable transfection 
studies, respectively. Western blot analysis confi  rmed that both the 
with mitotic centrosomes (0%,   n   = 113), whereas Cdc14B 
WT -
GFP associated with a majority (61%,   n   = 374) of mitotic centro-
somes examined. This fi   nding suggests that the failure of 
Cdc14B 
C314S   centrosomal retention is not because of the lack of 
  Figure 2.       Role of phosphatase activity and nucleocytoplasmic transport 
in Cdc14B centrosome localization  . (A) Cdc14B-GFP fusion proteins were 
induced by DOX for 72 h in U2OS Tet-On stable cell lines carrying dif-
ferent Cdc14B-GFP constructs as indicated. Centrosomes were visualized 
by     -tubulin staining (red) and overlaid with Cdc14B-GFP (green) and 
DAPI-stained DNA (blue). Cdc14B 
C314S  -GFP was not detectable at inter-
phase or mitotic centrosomes (arrows). Insets represent magniﬁ  ed images 
of centrosomes. Bar, 5   μ  m. (B) Histogram shows the percentage of inter-
phase and mitotic cells with the indicated Cdc14B-GFP at centrosomes 
72 h after DOX addition. The interphase data represent the means   ±   SD 
of three independent experiments and at least 500 cells were counted in 
each experiment. The mitotic experiment was performed in triplicates and 
a total of 113 Cdc14B 
C314S  -GFP  –   and 374 Cdc14B 
WT  -GFP  –  positive cells 
were counted.     JCB • VOLUME 181 • NUMBER 3 • 2008  478
  To determine if the observed supernumerary centrioles may 
derive from centrosome fragmentation, we carefully evaluated 
the     -tubulin  –  decorated centrosomes in HeLa cells transiently 
transfected with the Cdc14BsiRNA SMARTpool. We found 
that a majority of the supernumerary centrosomes were clus-
tered together and similar in size (  Fig. 3 E  ). All the super-
numerary centrosomes (  n   = 105) contained centrin-labeled 
centrioles and many of the centrioles were in pairs. These data 
suggest that the supernumerary centrosomes may not arise from 
centrosome fragmentation. 
  Examination of TREx-HeLa Cdc14BsiRNA stable cells 
revealed a slight increase in the number of polyploid cells, 
such as multinucleate and macronuclear cells (Fig. S3 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710127/DC1). 
siRNA pool and the shRNA specifi  cally knocked down Cdc14B 
but not its Cdc14A paralogue in HeLa cells (  Fig. 3 D  , top). 
Moreover, knockdown of Cdc14B by both the siRNA pool and 
shRNA led to a signifi  cant accumulation of cells with more than 
four centrioles in HeLa cells (  Fig. 3 D  , bottom). Although HeLa 
cells have been widely used for centrosome studies, it is a tumor 
cell line. To examine the effect of Cdc14B on centrosome cycle 
control in normal cells, we transfected normal human fi  broblast 
BJ and MRC-5 cells with the Cdc14B siRNA SMARTpool. 
As shown in   Fig. 4  , the centriole amplifi  cation phenotype was 
faithfully reproduced in the normal fi  broblast cells depleted of 
Cdc14B. These results demonstrate that depletion of Cdc14B 
leads to centrosome amplifi  cation in both normal and trans-
formed cells. 
  Figure 3.       Depletion of Cdc14B leads to centriole ampliﬁ  cation in HeLa cells  . (A) Western blot analysis using an anti-Cdc14B antibody showed Cdc14B 
knockdown in TREx-HeLa Cdc14BsiRNA stable clones No. 2 and 3 but not in TREx HeLa and clone No. 1. The same Cdc14BsiRNA also led to Cdc14B-GFP 
knockdown in U2OS Tet-On cells visualized by immunoblotting with anti-GFP antibody.     -actin was used as a loading control. (B) Images of supernumerary 
centrioles in Cdc14B knockdown HeLa cells. Centrioles were visualized by an anti-centrin antibody. Insets show magniﬁ  ed images of centrioles. Bar, 4   μ  m. 
(C) The percentage of cells with more than four centrioles was calculated from the experiments shown in A and B (left). Note that the data shown here does 
not include polyploid cells described in Fig. S3 A (available at http://www.jcb.org/cgi/content/full/jcb.200710127/DC1). (D, top) Immunoblot shows 
the level of endogenous Cdc14B and Cdc14A in HeLa cells transfected with siGLO control oligos (lane 1), Cdc14BsiRNA SMARTpool (lane 2), pSuper 
empty vector (lane 3), and pSuper-Cdc14BshRNA-E9 (lane 4). (bottom) HeLa cells were transfected with the corresponding oligos and vectors as in the top 
panel. Percentages of cells with more than four centrioles were calculated from experiments shown in B (middle and right). All the data are presented as 
the means   ±   SD of three independent experiments. At least 300 cells were counted in each experiment. Note that the indicated fold changes in A and D 
(top) were calculated based on the densitometric values of each lane normalized against the     -actin loading controls. (E) Supernumerary centrosomes in 
Hela cells transiently transfected with Cdc14BsiRNA SMARTpool were not the products of centrosome fragmentation. Note that all the     -tubulin  –  decorated 
centrosomes were similar in size and contained centrin-labeled centrioles, and that most of the centrioles were in pairs. Bar, 5   μ  m.     479 CDC14B, A NEGATIVE REGULATOR OF CENTRIOLE DUPLICATION   •   Wu et al.
whether localization of Cdc14B at centrioles conveys a critical 
function in centriole duplication. The number of centrin-labeled 
centrioles was counted in the inducible Cdc14B 
WT  -GFP cells af-
ter cultivation in the presence of HU without DOX induction, and 
HU + DOX for 72 h. As expected, HU treatment led to centriole 
amplifi  cation in uninduced Cdc14B 
WT  -GFP cells (  Fig. 5 A  , bot-
tom) or mock-transfected U2OS Tet-On cells (  Fig. 5 B  ). Remark-
ably, this centriole amplifi  cation phenotype was signifi  cantly 
attenuated in cells where Cdc14B 
WT  -GFP was at centrioles but 
not in cells where Cdc14B 
WT  -GFP was not at centrioles (  Fig. 5 A  ). 
This fi  nding was confi  rmed in the same sets of cells treated 
with HU + DOX for 72 h using     -tubulin as a centrosome marker 
(Fig. S4, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200710127/DC1). Similar and yet more dramatic results 
were obtained in transient transfection experiments in which cells 
transfected with DOX-inducible Cdc14B 
WT  -GFP exhibited an even 
more signifi  cant reduction of HU-induced centrosome amplifi  ca-
tion in comparison with the mock-transfected cells (  Fig. 5 B  ). 
Together, these results suggest that Cdc14B overexpression 
suppresses abnormal centriole amplifi  cation, and this inhibitory 
function requires the presence of Cdc14B-GFP at centrioles in 
the HU-induced centriole overduplication system. Fluorescence-
activated cell sorting analysis revealed that induction of Cdc14B-
GFP did not perturb cell cycle progression at the expression level 
set by the DOX-inducible promoter (  Fig. 5 C  ), which suggests 
that the inhibition of centriole amplifi  cation in HU-arrested cells 
was not the result of a potential G1 cell cycle arrest. 
  Cdc14B phosphatase activity is essential 
to prevent centriole overduplication in 
prolonged S phase  –  arrested cells 
  To investigate whether inhibition of centriole overduplication in 
HU-arrested U2OS cells requires the presence of active Cdc14B 
at centrioles, we took advantage of and tested the centriole-bound 
Macronuclear and multinucleate cells were determined by visual 
judgment of the sizes (nuclear diameter and area) of DAPI-stained 
nuclei and the number of nuclei per cell, respectively. It is impor-
tant to note that among the TREx-HeLa Cdc14BsiRNA stable 
cells with centriole amplifi  cations, only    0.2  ( n   = 300) were 
polyploid. Using the same criteria, we were unable to detect any 
signifi  cant increase of polyploid cells in HeLa cells transiently 
transfected with Cdc14BsiRNA SMARTpool (Fig. S3 B). In line 
with this fi  nding, fl  ow cytometry analysis did not reveal any sig-
nifi  cant increase of polyploidy in those Cdc14B knockdown cells 
(Fig. S3 C). Moreover, none of the Cdc14B-depleted BJ (0%; 
  n   = 115) or MRC-5 (0%;   n   = 74) cells with more than four centri-
oles were polyploid. Thus, the centriole amplifi  cation phenotype 
in Cdc14B knockdown cells may not be the product of aborted 
cell division, and the slight increase in the number of polyploid 
cells in the TREx-HeLa Cdc14BsiRNA stable clones may have 
evolved during the course of stable clone selection. 
  Ectopic expression of centriole-associated 
Cdc14B inhibits centriole overduplication 
in prolonged S phase  –  arrested cells 
  In certain transformed cells, such as U2OS cells, prolonged 
S phase arrest by hydroxyurea (HU) causes multiple rounds of 
centriole duplication in the absence of DNA replication and mi-
totic division (  Balczon et al., 1995  ;   Chang et al., 2003  ). We there-
fore used this well-established centriole overduplication system 
to directly evaluate whether Cdc14B plays a role in the regulation 
of centriole duplication. For this purpose, we fi  rst tested if Cdc14B 
overexpression could inhibit HU-induced centriole overduplica-
tion in the stable doxycycline (DOX)-inducible Cdc14B 
WT -GFP 
U2OS Tet-On cells. Based on the localization of Cdc14B 
WT -GFP 
at centrioles (  Fig. 2  ), the Cdc14B 
WT -GFP – positive  cells  can  be 
divided into two groups: Cdc14B 
WT  -GFP at centrioles and not 
at centrioles. This provides an ideal system to directly examine 
  Figure 4.       Depletion of Cdc14B causes centriole ampliﬁ  cation 
in normal human ﬁ  broblast cells  . (A) Representative confocal 
images of BJ and MRC-5 cells with clustered supernumerary 
centrioles are shown. Centrioles were labeled by anti-centrin 
antibody. Insets show magniﬁ  ed images of centrioles. Bar, 
10   μ  m. (B) The percentage of cells with more than four centri-
oles was calculated from the experiments shown in A. Data 
shown represent the means   ±   SD of three independent experi-
ments. At least 300 cells were counted in each experiment.     JCB • VOLUME 181 • NUMBER 3 • 2008  480
inhibition of centriole duplication and that docking a catalyti-
cally inactive Cdc14B-GFP to centrioles is not suffi  cient to pre-
vent centriole overduplication. 
  Inhibition of Z-L  3  VS  –  induced centriole 
overduplication requires Cdc14B 
phosphatase activity 
  It has been documented that treatment of U2OS cells with a 
proteasome inhibitor Z-L  3  VS causes multiple daughter centri-
ole growth from a single mother centriole template (  Duensing 
et al., 2007  ). This aberrant daughter centriole overduplication 
requires cyclin E/Cdk2 and Plk4, the known positive regula-
tors of centriole duplication (  Nigg, 2007  ). We thus used the 
catalytic dead Cdc14B 
K & C  -GFP mutant as described in   Fig. 2  . 
When the Cdc14B 
K & C  -GFP cells were exposed to HU, the 
DOX-induced Cdc14B 
K & C  -GFP was unable to block centriole 
overduplication, whereas the centriole-associated catalytic   “  ac-
tive ”   Cdc14B 
KKIR   mutant (  Fig. 2  ) was as potent as its wild-type 
counterpart in inhibition of centriole overduplication (  Fig. 5 A  ). 
Similar results were obtained when the HU-treated cells were 
examined by     -tubulin staining (Fig. S4, A and B). Western blot 
revealed that all the Cdc14B-GFPs were expressed at the com-
parable level after Dox induction (Fig. S4 C), indicating that the 
failure of Cdc14B 
K & C  -GFP to inhibit centriole overduplication 
was not caused by its expression level. This fi  nding strongly ar-
gues that Cdc14B phosphatase activity is indispensable for the 
  Figure 5.       Cdc14B phosphatase activity is required to prevent HU-induced centriole ampliﬁ  cation  . (A, top) Cdc14B-GFP fusion proteins were induced by 
4   μ  g/ml DOX in the presence of 2 mM HU for 72 h in U2OS Tet-On stable cell lines carrying different Cdc14B-GFP constructs as indicated. Centrioles were 
visualized by anti-centrin staining (red) and overlaid with Cdc14B-GFP (green) and DAPI (blue). Note that Cdc14B 
C314S  -GFP was not detectable at centri-
oles (arrow). Insets show magniﬁ  ed images of centrioles. Bar, 5   μ  m. (bottom) The percentage of cells with more than four centrioles was calculated from 
both induced (+DOX) and uninduced (    DOX) Cdc14B-GFP stable clones as indicated. Data shown represent the means   ±   SD of three independent experi-
ments from two individual Cdc14B-GFP stable clones. At least 500 cells were counted in each experiment. (B, top) U2OS Tet-On cells were transfected as 
indicated. 16 h after transfection, cells were incubated with (+HU) or without (    HU) 2 mM HU and 4   μ  g/ml DOX for 72 h. Centrosomes were visualized 
by     -tubulin staining (red). Representative centrosome ampliﬁ  cation was detected in mock-transfected cells after HU treatment but not in pBI-tet-Cdc14B 
WT  -
GFP transfected cells where Cdc14B 
WT  -GFP (green) associated with centrosomes. Insets show magniﬁ  ed images of centrosomes. DAPI (blue), DNA. Bar, 
5   μ  m. (bottom) The percentage of cells with the indicated centrosome numbers was calculated from the experiments shown in the top panel. Centrosomes 
were counted in both mock and Cdc14B-GFP  –  transfected cells (Cdc14B-GFP  –  positive at centrosomes). All the data are shown as the means   ±   SD of three 
independent experiments. At least 500 cells were counted in each experiment. (C) Representative ﬂ  uorescence-activated cell sorting proﬁ  le on cell cycle 
distribution of DOX-inducible Cdc14B-GFP U2OS Tet-On stable clones. Cells were cultivated in the presence or absence of 4   μ  g/ml DOX for 72 h. Positions 
of cells with 2 N and 4 N DNA contents are labeled with arrowheads.     481 CDC14B, A NEGATIVE REGULATOR OF CENTRIOLE DUPLICATION   •   Wu et al.
  centrosome splitting (  Meraldi and Nigg, 2001  ). A similar mecha-
nism may prevail in the regulation of centrosome duplication 
(  Nigg, 2007  ). To our knowledge, Cdc14B is the only phospha-
tase identifi  ed as a negative regulator of centrosome duplication, 
though a recent study shows that another phosphatase, Cdc25B, 
also regulates centrosome duplication, albeit as a positive regula-
tor (  Boutros et al., 2007  ). It is possible that Cdc14B may act to 
keep the centrosomes in check before and/or after centrosome 
duplication by opposing the activities of Cdk2 and other related 
kinases required for the initiation of centrosome duplication. 
It has been demonstrated that mammalian Cdc14s preferen-
tially dephosphorylate Ser/Thr-proline  –  directed sites of Cdk-
phosphorylated substrates (  Li et al., 2000  ;   Kaiser et al., 2002  ). 
Cdk2/cyclin E and A are involved in the initiation of centrosome 
duplication in cycling cells (  Hinchcliffe et al., 1999  ;   Meraldi et al., 
1999  ). In this context, Cdc14B may oppose cyclin A/Cdk2 
activity to prevent centrosome reduplication because centrosome 
duplication terminates at the end of S phase and cyclin A/Cdk2 
is still active throughout S phase and early mitosis (  Pagano et al., 
1992 ).  Cdc14B may also stabilize Cdk inhibitor 1/Kip1 (  Saito 
et al., 2004  ) by promoting dephosphorylation-dependent Skp2 
degradation (  Rodier et al., 2008  ), which in turn inhibits Cdk2/
cyclin E activity in G1 to prevent premature centriole duplication. 
Recent studies suggest that Plk4 plays an important role in trigger-
ing procentriole assembly (  Kleylein-Sohn et al., 2007  ) and, thus, 
uncontrolled activation may impose risks of abnormal procentri-
ole growth (  Habedanck et al., 2005  ). Under this circumstance, 
Plk4 activity may call for scrupulous counterbalance by Cdc14B-
like phosphatases, though centrosomal substrates of Plk4 and 
Cdc14B remain unknown and the consensus phosphorylation 
motif of Plk4 substrates (  Leung et al., 2007  ) may not conform to 
a typical Ser/Thr-proline motif of Cdc14B substrates. 
Z-L  3  VS  –  induced centriole duplication system to evaluate the 
possibility of Cdc14B as a counterbalancing enzyme of cyclin 
E/Cdk2 and/or Plk4 in centriole duplication control. In the ab-
sence of Cdc14B 
WT  -GFP induction (    DOX), treatment of U2OS 
Tet-On – Cdc14B 
WT  -GFP cells with Z-L  3  VS evoked an aberrant 
centriole overgrowth, whereas in the presence of Cdc14B 
WT -
GFP induction (+DOX), centriole-bound Cdc14B 
WT -GFP  sig-
nifi  cantly attenuated the centriole overduplication phenotype 
(  Fig. 6  ). Moreover, similar to our observation in the HU experi-
ment (  Figs. 5   and S4, A and B), the centriole-bound catalytic dead 
Cdc14B 
K & C   mutant failed to prevent Z-L  3 VS – induced  centriole 
overduplication (  Fig. 6  ), indicating that this inhibition requires 
Cdc14B catalytic activity. Although additional experiments are 
required, our study supports the possibility that Cdc14B may 
counterbalance centrosomal kinases required for centriole over-
duplication in the Z-L  3  VS induction system. 
  Discussion 
 The  fi  ndings that depletion of Cdc14B leads to centriole ampli-
fi  cation and that overexpression of Cdc14B inhibits HU- and 
Z-L  3  VS  –  induced centriole overduplication imply that Cdc14B 
may play a pivotal role in the regulation of centriole duplication 
cycle. Because catalytic activity of Cdc14B is required to har-
ness centriole overduplication in both HU- and Z-L  3 VS  experi-
mental systems, Cdc14B may exert its effect through modulating 
the phosphorylation status of its substrates, in particular those 
involved in the control of centrosome duplication. It has been 
well documented that the activities of centrosome-associated 
protein kinases, such as Cdk2/cyclin E/A, Plk2, Plk4, calcium-
calmodulin kinase II, MpsI, and Zyg-1, are required for centriole 
duplication in various species and experimental settings including 
the HU- and Z-L  3 VS – induced centriole overduplication systems 
(  Matsumoto et al., 1999  ;   Meraldi et al., 1999  ;   Fisk and Winey, 
2001 ;  O ’ Connell et al., 2001 ;  Matsumoto and Maller, 2002 ;  Fisk 
et al., 2003  ;   Warnke et al., 2004  ;   Habedanck et al., 2005  ;   Tsou 
and Stearns, 2006b  ;   Duensing et al., 2007  ;   Kleylein-Sohn et al., 
2007  ), which suggests that phosphorylation plays an important 
role for the precise reproduction of centrosomes during the cell 
cycle (  Tsou and Stearns, 2006a  ;   Nigg, 2007  ). Phosphorylation 
of centrosome-associated proteins such as nucleophosmin/B23, 
CP110, and Mps1 has been implicated in centrosome duplica-
tion control. In particular, phosphorylation of B23 Thr199 by 
Cdk2/cyclin E and of B23 Thr95 by an unknown kinase disso-
ciates B23 from centrosomes, which in turn allows centrosome 
duplication or reduplication to occur ( Okuda et al., 2000 ;  Budhu 
and Wang, 2005  ). Likewise, depletion of CP110 abolishes centro-
some reduplication in S phase – arrested cells ( Chen et al., 2002 ) and 
suppresses Plk4-induced procentriole reduplication ( Habedanck 
et al., 2005  ), whereas inactivation of Cdk2 activity abolishes 
Mps1-dependent centrosome duplication (  Fisk and Winey, 2001  ). 
Based on our observation in this study, it is possible that Cdc14B 
may regulate the centriole duplication cycle by modulating the 
phosphorylation status of centrosomal proteins such as B23, 
CP110, and Mps1. 
  A counterbalance of kinase and phosphatase activities 
  involving Nek2 and PP1     has been proposed for governing 
  Figure 6.       Cdc14B phosphatase activity is required to prevent Z-L  3  -VS  – 
induced centriole overduplication.   (A) Dox-inducible U2OS Tet-On cell lines 
carrying the indicated Cdc14B-GFPs and mock controls were treated with 
1   μ  M Z-L  3  -VS in the presence or absence of 4   μ  g/ml Dox for 48 h. Repre-
sentative centrioles (red) were visualized by an anti-centrin antibody and 
DNA (blue) was visualized by DAPI. Bar, 5   μ  M. (B) The percentage of cells 
with more than four centrioles was calculated from the experiments shown 
in A and as indicated. Centrioles were counted in mock, uninduced controls 
(    Dox) and Cdc14B-GFP  –  induced (+Dox) cells (Cdc14B-GFP  –  positive at 
centrioles). All the data are shown as the means   ±   SD of three independent 
experiments. At least 400 cells were counted in each experiment.     JCB • VOLUME 181 • NUMBER 3 • 2008  482
  Immunoﬂ  uorescence 
  For indirect immunoﬂ  uorescence, cells were grown on glass coverslips 
and ﬁ   xed with either paraformaldehyde or cold 100% methanol. The 
cells were then permeabilized with PBS/0.5% Triton X-100 for 10 min 
followed by blocking with PBS/1% BSA for 30 min. Centrosomes or centri-
oles were visualized by immunostaining with antibodies against     -tubulin 
(GTU-88 [Sigma-Alrich] and C-20 [Santa Cruz Biotechnology, Inc.), peri-
centrin (Abcam), or centrin (20H5; a gift from J. Salisbury, Mayo Clinic 
Foundation, Rochester, MN). For visualization of centriole-associated 
endogenous Cdc14B, cells were treated with or without 10   μ  g/ml no-
codazole (for better exposure of centrosomal Cdc14B) for 2 h, brieﬂ  y ex-
tracted with 0.5% Triton X-100 on ice, ﬁ  xed with cold 100% methanol, 
and immunostained with chicken anti-Cdc14B antibody (GenWay Bio-
tech, Inc.). In our hands, methanol ﬁ  xation preserved GFP signals and, 
thus, anti-GFP immunostaining was not used to visualize Cdc14B-GFP fu-
sion proteins in the ﬁ   xed cells. Secondary antibodies including Alexa 
Fluor 488 and 594 donkey anti  –  mouse and anti  –  goat and goat anti  –  rabbit, 
and anti  –  chicken IgY antibodies were obtained from Invitrogen. DNA 
was counterstained by DAPI. Cells were visualized with a 100  ×   Plan 
Neoﬂ  uar objective (1.30 oil;     /0.17; Carl Zeiss, Inc.) under an epiﬂ  uo-
rescence microscope (Axioskop 2; Carl Zeiss Inc). Images were acquired 
with a charge-coupled device camera (AxioCam HRC; Carl Zeiss, Inc.) 
controlled by Openlab software (version 3.5; PerkinElmer). For confocal 
microscopy, images were captured with an HCX-PL/APO 63 X 1.32 oil 
objective (Leica) under a SP2 laser scanning confocal microscope (Leica) 
equipped with confocal software (LCS version 2.0; Leica). The coverslips 
were mounted using PermaFlour Mountant media (Thermo Fisher Scien-
tiﬁ  c) and imaging was performed at room temperature. Image processing 
was performed using Photoshop CS (8.0). 
  Centrosome fractionation experiments 
  Centrosomes were prepared from exponentially growing HeLa cells 
according to a previously published procedure (  Moudjou and Bornens, 
1998  ). In brief, a total of 6   ×   10 
8   cells were treated with 1   μ  g/ml cytocha-
lasin D and 2.2   μ  M nocodazole. Cells were lysed in a buffer containing 1 M 
Hepes, pH 7.2, 0.5% NP-40, 0.5 mM MgCl  2  , 0.1%     -mercaptoethanol, 
and protease inhibitor cocktail (Roche) and centrifuged at 2,500   g  . The re-
sulting supernatant was ﬁ   ltered, incubated with 2 U/ml DNase I, and 
loaded over a 60% sucrose cushion for centrifugation at 10,000   g   with a 
SW28 rotor (Beckman Coulter). Concentrated centrosomes were centri-
fuged again over a discontinuous gradient containing 70, 50, and 40% 
sucrose solutions at 75,000   g  . A total of 32 fractions were collected from the 
bottom of the tube. Each fraction was separated by SDS-PAGE. Centrosome-
enriched fractions were determined by immunoblotting with anti  –      -tubulin 
antibody, and the presence of Cdc14B was judged by immunoblotting 
with anti-Cdc14B antibody (Invitrogen). For immunoﬂ  uorescence analysis 
of isolated centrosomes, each 10   μ  l of fraction 15 was diluted into 4 ml of 
10 mM Pipes buffer, pH 7.2, and transferred into a 38.5-ml ultracentrifuge 
tube (Beckman Coulter) with a specially designed adaptor to ﬁ  t to a 15-mm 
round coverslip. The samples were then subjected to centrifugation at 
20,000   g   (10,000 rpm) for 20 min with a SW28 rotor followed by ﬁ  xa-
tion in methanol at     20  °  C for 10 min and immunostaining with antibodies 
against centrin, Cdc14B (GenWay Biotech, Inc.), and nucleolin (4E2; 
Research Diagnostics, Inc.), respectively. Finally, coverslips were placed in 
pure ethanol for 2 min at room temperature, air-dried, and mounted with 
a drop of Permaﬂ  our (Thermo Fischer Scientiﬁ  c) on a microscope slide. 
Images were captured as described in the preceding paragraph. 
  Online supplemental material 
  Fig. S1 shows that a fraction of Cdc14B-GFP associates with centrioles. 
Fig. S2 shows the speciﬁ  cities of Cdc14B and     -tubulin antibodies, and 
centrosome ampliﬁ  cation in Cdc14B knockdown cells. Fig. S3 shows poly-
ploidy cells in Cdc14BsiRNA stable clones. Fig. S4 shows that Cdc14B 
catalytic activity is required to prevent HU-induced centrosome overdu-
plication. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200710127/DC1. 
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  Cdc14B has been implicated in the regulation of nuclear 
structure maintenance (  Nalepa and Harper, 2004  ), microtubule 
dynamics (  Cho et al., 2005  ), mitotic exit control (  Dryden et al., 
2003  ), and G1 progression (  Rodier et al., 2008  ). The abnormal 
centrosome amplifi  cation observed in Cdc14B-depleted cells may 
arise from the combinatorial events involving failures in nuclear 
structure, cell, and centrosome cycle regulation. However, be-
cause active Cdc14B can directly inhibit unscheduled centriole 
overduplication, and Cdc14B depletion leads to centriole ampli-
fi  cation in the absence of obvious polyploidy in normal human 
fi  broblast cells, it is possible that one of Cdc14B functions is 
to serve as a centrosomal regulatory protein, and compromising 
centrosomal regulatory function of Cdc14B may account for 
at least part of the observed centriole amplifi  cation phenotype. 
Because it is frequently down-regulated in tumor cells ( Wong et al., 
1999  ;   Martinez et al., 2003  ;   Ashida et al., 2004  ;   Yu et al., 2004  ; 
  Neben et al., 2005  ;   Rubio-Moscardo et al., 2005  ), Cdc14B may 
function as a tumor suppressor to maintain the fi  delity of the 
centrosome duplication cycle and genomic stability in human cells. 
  Materials and methods 
  Cell culture, transfection, drug treatment, and cell cycle analysis 
  U2OS Tet-On (BD Biosciences), HeLa, and TREx HeLa (Invitrogen) cells 
were cultured as described previously (  Cho et al., 2005  ). Normal human 
ﬁ  broblast BJ and MRC-5 cells were obtained from the American Type Cul-
ture Collection and maintained in Dulbecco  ’  s modiﬁ  ed  Eagle  ’  s medium 
supplied with 10% fetal bovine serum, 50 U/ml penicillin, and 50   μ  g/ml 
streptomycin. To establish DOX-inducible Cdc14B-GFP stable clones, the 
pBI-tet-Cdc14B 
WT  , pBI-tet-Cdc14B 
KKIR  , pBI-tet-Cdc14B 
C314S  , or pBI-tet-Cdc14B 
K  &  C   
plasmid (  Cho et al., 2005  ) was cotransfected with pBabe-puro into U2OS 
Tet-On cells harboring endogenous Cdc14B by FuGene6 (Roche). Stable 
clones were obtained after selection with 500   μ  g/ml G418 and 2   μ  g/ml 
puromycin in the absence of DOX. For the prolonged S phase arrest exper-
iment, the Cdc14B-GFP stable clones were treated with or without 4   μ  g/ml 
DOX, 2 mM HU (Sigma-Aldrich) alone, or 2 mM HU and 4   μ  g/ml DOX 
together for 72 h. For the Z-L  3  VS experiment, Cdc14B-GFP stable clones 
were treated with 1   μ  M of Z-L  3  VS (BIOMOL International, L.P.) in the pres-
ence or absence of 4   μ  g/ml DOX for 48 h. For cell cycle analysis, cells 
were stained with a buffer containing 1   μ  g/ml propidium iodide, 0.6% 
NP-40, 0.1% sodium citrate, and 20   μ  g/ml RNase A and analyzed by a 
ﬂ  uorescence-activated cell sorter (Guava Technologies, Inc.). The percent-
age of cells in difference phases of the cell cycle was determined using 
ModFit LT software (Verity Software House). 
  siRNA and shRNA experiments 
  Cdc14B protein was depleted using the following three approaches. First, 
siRNA oligos that target the sequences 5    -GAACCCGAACCGTACAGTG-3     
(1,234  –  1,254, relative to the start codon of Cdc14B) were annealed and 
cloned into the HindIII and BglII sites of pSuperior-neo-GFP vector (Oligo-
engine). Tetracycline-inducible cell lines expressing pSuperiorCdc14B siRNA 
were generated by cotransfection with pBabe-puro into TREx-HeLa cells that 
contain Tet repressors. Stable clones were established by selection in a 
growth medium containing 800   μ  g/ml G418 and 1   μ  g/ml puromycin in the 
absence of tetracycline. Second, an shRNA expression vector carrying a 
Cdc14B shRNA oligo (989  –  1,017, relative to Cdc14B start codon) was ob-
tained from Open Biosystems and subcloned into the pSuper-neo-GFP vector 
(Oligoengine), which was designated as pSuper-Cdc14BshRNA-E9. Stable 
transfectants were obtained by cotransfection with pBabe-puro into HeLa 
cells followed by selection with 800   μ  g/ml G418 and 1   μ  g/ml puromycin. 
Third, Cdc14B siRNA SMARTpool (targeting four different regions of 
Cdc14B mRNA sequences) and an siGLO control oligo were obtained from 
the siGENOME collection (Thermo Fisher Scientiﬁ   c) and transfected into 
HeLa, BJ, and MRC-5 cells using siPORT NeoFX reagent (Ambion) according 
to the manufacturer  ’  s instructions followed by a 66-h incubation. Cell lysates 
were then prepared and subjected to SDS-PAGE. Western blots were per-
formed using anti-Cdc14A (Invitrogen), -Cdc14B (Invitrogen), -GFP (BD Bio-
sciences), and   –      -actin (Cytoskeleton, Inc.) antibodies. 483 CDC14B, A NEGATIVE REGULATOR OF CENTRIOLE DUPLICATION   •   Wu et al.
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